A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

By sjmartinez • March 7, 2025

Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Feb 19;7(1):vdaf022. doi: 10.1093/noajnl/vdaf022. PMID: 40051661; PMCID: PMC11883343.

Tags: Cardiology/Epi, EGFR, FDG PET, Glioblastoma, imaging biomarker, molecular imaging, Osimertinib, Publications

Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Median Survival Among Patients Hospitalized[...]

Adult congenital cardiac interventional training, competencies, and organization. A Statement of the ESC ACHD Working Group, the EAPCI, the AEPC, and the PICS-Society

Chessa M, Brida M, Budts W, Chieffo A, Dua J, Kaleschke G, Kempny A, Kenny D, Krasemann T, Rahbek Schmidt M, Aboulhosn J. Adult congenital[...]

Comprehensive macroscopic living anatomy of the swine heart: comparative visual approach with virtual dissection

Rios KP, Moussa AM, Rios HA, Rimmer M, Miyazaki Y, Aoyama D, Aladham RN, Defelice LG, Hanna P, Hayase JH, Chung WH, Xu S, Ajijola[...]